PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)

Title
PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)
Authors
Keywords
-
Journal
VALUE IN HEALTH
Volume 15, Issue 4, Pages A38
Publisher
Elsevier BV
Online
2012-05-24
DOI
10.1016/j.jval.2012.03.215

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started